Skip to main content

KOURZEQ

Generic: Triamcinolone Acetonide

Verified·Apr 23, 2026
Manufacturer
Kylara Pharmaceuticals
NDC
82682-001
RxCUI
1085728
Route
TOPICAL
ICD-10 indication
K12.1

Affordability Check

How much will you actually pay for KOURZEQ?

In 30 seconds, see every legitimate way to afford KOURZEQ — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About KOURZEQ

What is this medication? KOURZEQ is a prescription corticosteroid medication formulated as a dental paste that contains triamcinolone acetonide. It is specifically designed for topical application to the lining of the mouth to provide temporary relief from symptoms associated with oral inflammatory and ulcerative lesions. This medication is most commonly used to treat aphthous stomatitis, frequently referred to as canker sores, as well as lesions resulting from physical trauma to the oral tissues. The dental paste works by creating a protective film over the affected area, which helps the active ingredient stay in contact with the sore while shielding it from further irritation. By suppressing the immune system response in the localized area, it helps reduce pain, redness, and swelling to facilitate comfort during the healing process. Patients are generally advised to apply a small amount of the paste to the lesion, often at bedtime, to allow the medication to work effectively without being washed away by saliva or disrupted by eating and drinking.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for KOURZEQ. Official source: DailyMed (NLM) · Label effective Nov 18, 2025

Indications and usage
INDICATIONS AND USAGE KOURZEQ is indicated for adjunctive treatment and for the temporary relief of symptoms associated with oral inflammatory lesions and ulcerative lesions resulting from trauma.
Dosage and administration
DOSAGE AND ADMINISTRATION Press a small dab (about ¼ inch) to the lesion until a thin film develops. A larger quantity may be required for coverage of some lesions. For optimal results use only enough to coat the lesion with a thin film. Do not rub in. Attempting to spread this preparation may result in granular, gritty sensation and cause it to crumble. After application, however, a smooth, slippery film develops. The preparation should be applied at bedtime to permit steroid contact with the lesion throughout the night. Depending on the severity of symptoms, it may be necessary to apply the preparation two or three times a day, preferably after meals. If significant repair or regeneration has not occurred in seven days, further investigation is advisable.
Contraindications
CONTRAINDICATIONS Triamcinolone Acetonide Dental Paste USP, 0.1% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations; it is also contraindicated in the presence of fungal, viral, or bacterial infections of the mouth or throat.
Adverse reactions
ADVERSE REACTIONS The following local adverse reactions may occur with corticosteroid-containing dental pastes: burning, itching, irritation, dryness, blistering or peeling not present prior to therapy, perioral dermatitis, allergic contact dermatitis, maceration of the oral mucosa, secondary infection, and atrophy of the oral mucosa. Also, see PRECAUTIONS for potential effects of systemic absorption.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How KOURZEQ appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

56%

3,066 of 5,509 plans

Most common tier

Tier 3

On 42% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)46
20%
Tier 2 (generic)73
32%
Tier 3 (preferred brand)96
42%
Tier 4 (non-preferred brand)16
7%

Step therapy: 0% of formularies

Quantity limits: 0% of formularies

Coverage breadth: 231 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.